Literature DB >> 31108179

Successful oral desensitization with dasatinib in delayed cutaneous hypersensitivity reactions.

Betul Karaatmaca1, Selin Aytac2, Umit Murat Sahiner1, Bulent Enis Sekerel1, Ozge Soyer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31108179     DOI： 10.1016/j.anai.2019.05.011

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  3 in total

Review 1.  Hypersensitivity Reactions to Biologicals: from Bench to Bedside.

Authors:  Aysegul Akarsu; Ozge Soyer; Bulent Enis Sekerel
Journal:  Curr Treat Options Allergy       Date:  2020-01-18

2.  Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies.

Authors:  Arantza Vega; M Isabel Peña; Inés Torrado
Journal:  Front Allergy       Date:  2022-01-14

3.  Bosutinib-Induced Stevens-Johnson Syndrome and Evidence of Tolerance to a Structurally Dissimilar Tyrosine Kinase Inhibitor.

Authors:  Karol Avila-Castano; Dan Morgenstern-Kaplan; Ismael Carrillo-Martin; Alexei Gonzalez-Estrada
Journal:  Cureus       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.